0 participants
Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-15
- Start Date:
- 2024-10-21
- Completion:
- 2024-10-21
Conditions
- Leukemia
Interventions
- DRUG
No Results Yet